Agreement - May 13, 2025
Recipharm enters strategic partnership with ProductLife Group
This collaboration represents a powerful alignment of capabilities designed to address the growing complexity of global regulatory requirements, the companies state.
CDMO - April 15, 2025
New European CDMO launched, with site in Sweden
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions, has launched with an integrated network across Europe.
Biotech article - March 19, 2025
Scaling the next generation of T-cell therapy
Understanding the science is one thing, but being able to manufacture T-cell therapies at scale is a different matter. TCR-T cell therapies offer a path forward at a fraction of the cost and time of manufacturing a living cell as a product.
CDMO - February 4, 2025
3PBIOVIAN to collaborate with Eleva
The two companies have announced a strategic alliance to collaborate on the manufacturing of current pipeline programs and potential future programs based on Eleva's technology platform.
Biotech Business - January 15, 2025
NOK 50 million to new Norwegian ATMP infrastructure
The Research Council of Norway has granted NOK 50 million to the Oslo University Hospital (OUH), in partnership with the University of Oslo and the Haukeland University Hospital (HUH) for the development and distribution of ATMPs, reports Sofia Lindén/Oslo Cancer Cluster (OCC).
CDMO - January 14, 2025
ReciBioPharm secures grant to advance RNA manufacturing
ReciBioPharm, a division of Recipharm, has been awarded a three-year grant from the Bill & Melinda Gates Foundation.
